Open Access

Cerebral microbleeds in idiopathic normal pressure hydrocephalus

Fluids and Barriers of the CNS201613:4

https://doi.org/10.1186/s12987-016-0028-z

Received: 9 November 2015

Accepted: 3 February 2016

Published: 10 February 2016

Abstract

Background

A vascular disease could be involved in pathophysiology of normal pressure hydrocephalus (INPH). If so, there should be an association between INPH and cerebral microbleeds (CMB). This study aims to analyze if CMB are associated with INPH.

Methods

In this case-control study we included 14 patients with INPH (mean age 76 years, 60 % female) and 41 healthy controls (HeCo; mean age 71 years, 60 % female). All were investigated with magnetic resonance imaging (MRI) using a T2*-sequence. The MRI exams were reviewed by two neuroradiologists for the presence of CMBs; the prevalence of findings of two or more CMBs was compared between INPH group and control group. After investigation, INPH patients underwent shunt surgery.

Results

Two or more CMB were detected more frequently in the INPH group compared to HeCo (n = 6, 43 % vs. n = 4, 10 %; p = 0.01). Among the participants where MRI revealed CMB, the number of CMB was higher among the INPH patients than the HeCo (median 8; IQR 2-34 vs. median 1; IQR 1–2; p = 0.005).

Conclusions

This study supports a vascular component to the pathophysiology of INPH.

Keywords

Idiopathic normal pressure hydrocephalusMagnetic resonance imagingCerebral microbleeds

Background

Idiopathic normal pressure hydrocephalus is a syndrome featuring communicating hydrocephalus in combination with a symptom triad of balance- and gait-disturbance, cognitive decline and urinary incontinence. In Sweden, the prevalence in the 70–79 year age group is 0.2 %, rising to nearly 6 % in individuals over 80 years [1]. The pathophysiology is probably multi-factorial [2]. As INPH patients improve with cerebrospinal fluid (CSF) drainage, a CSF dynamic disturbance is usually considered the main etiological component. In recent years, small vessel disease has emerged as an alternative mechanism to explain part of the pathophysiological process in that vascular risk factors, manifest vascular disease, and white matter hyperintensities have all been associated with INPH [3].

Cerebral microbleeds are iron deposits in the brain that are associated pathologically with hemosiderin-laden macrophages [4]. Mainly located around small vessels, and revealed in iron-sensitive MRI sequences, CMB are associated with moderate cognitive decline, several causes of dementia and several vascular risk factors including age, hypertension, lacunar infarctions, white matter lesions and diabetes [49]. However, the association between CMB and INPH has not been studied. The vascular hypothesis that part of the INPH syndrome could be explained by small vessel disease, would be strengthened if there is an association between INPH and CMB. The aim of this study was to analyze if CMB are associated with INPH.

Methods

This was a retrospective case-control study. From a consecutive cohort of patients aged >40 years that underwent evaluation for ventriculomegaly, we included all (n = 14) patients that: (1) were classified as probable (n = 9) or possible (n = 5) INPH according to guidelines [10] (2) underwent shunt surgery and (3) were examined with MRI including a T2*-sequence preoperatively. The included patients were evaluated between January 2008 and March 2009. Mean Evans index was 0.40 (range 0.36–0.49). Mean symptom duration was 3.2 years (range 1–7). All INPH patients had gait disturbance (100 %), 13 (93 %) had incontinence and six (43 %) a mild cognitive impairment (defined as Mini Mental Examination score of 22–26). Cognitive status and number of vascular risk factors were not exclusion criteria for the INPH-patients as they were for the controls. All patients were treated with a ventriculo-peritoneal shunt. Post-operative improvement was defined as reduced need of walking aids and/or walking speed increased by >15 %, assessed by comparison of pre-operative and post-operative standardized exams of gait and walking speed performed by experienced physiotherapists at our neurology ward. The mean delay between surgery and post-operative assessment was 17 weeks (range 13–24 weeks). Post-operative follow-up was available in 13 patients. Of these 13 patients, ten (77 %) improved, one (8 %) did not improve despite that the shunt was patent. Two (15 %) patients died from perioperative complications within one month of the surgery.

Forty-one healthy controls (HeCo), who considered themselves healthy, were recruited between September 2007 and August 2008 through an advertisement in the local newspaper. HeCo were eligible if they did not have any psychiatric or neurologic disorder or signs of manifest atherosclerotic disease (such as stroke or myocardial infarction). Mini-mental state estimation ≥28 points was required, without any contraindication for MRI examination. Not more than two vascular risk factors out of smoking, hypertension and hyperlipidemia were accepted, potential controls with three vascular risk factors were not enrolled in the study.

All subjects (patients and HeCo) were examined with MRI using a hydrocephalus protocol with a Philips Achieva 3 Tesla machine and an 8-channel head coil. Beside standard T1, T2 and FLAIR sequences, the CMB were assessed using a T2*-weighted sequence (axial T2 FFE, 5 mm slice thickness and 1 mm intersection gap (FOV = 230 × 230 mm, matrix acquisition 512x512, TE/TR = 833 ms/16 ms). The occurrences of CMB were independently evaluated by two senior neuroradiologists (NB, RB) using the T2* images. The other MRI data were used to rule out CMB-mimics and disagreements were resolved by consensus decision. The number of microbleeds was assessed using the Microbleed Anatomic Rating Scale (MARS) [11].

CMB were analyzed using median, intra-quartile range (IQR). Mann–Whitney test was used to compared INPH and controls. Cohen’s Kappa values were calculated for inter-observer agreements. Where appropriate, we used 95 % CI, χ2-2-test and t test. A p value of <0.05 was pre-selected as the threshold for statistical significance. IBM SPSS v20.0 software was used for all statistical analyses.

The study was approved by the regional ethical review board at Umeå University.

Results

This study included 55 subjects; 41 healthy controls and 14 INPH patients. See Table 1 for baseline comparisons. Altogether, 249 CMBs were observed in all subjects. Among patients with INPH, the median number of CMB was 0.5 (IQR 0–8), and among HeCo the median number of CMB was 0 (IQR 0–1; p = 0.035). When only subjects with CMB were taken into account, the median number CMB was eight (IQR 2–34) in INPH and one (IQR 1–2) among the controls (p = 0.005).
Table 1

Baseline comparison between patients with idiopathic normal pressure hydrocephalus and healthy controls

 

INPH

(n = 14)

Healthy controls

(n = 41)

P value

Age mean (SD)

76.4 (5.1)

70.5 (5.4)

0.001*

Women n (%)

6 (43)

18 (44)

1.0a

Previous MI n (%)

0 (0)

0 (0)

NA

Previous stroke n (%)

0 (0)

0 (0)

NA

Current smoking n (%)

0 (0)

2 (5)

1.0a

Hypertensionb n (%)

12 (86)

28 (68)

0.30a

Treated hyperlipidemia n (%)

0 (0)

6 (15)

0.18a

0–2 risk factorsc

14 (100)

41 (100)

NA

3 risk factorsc

0 (0)

0 (0)

Anti-platelet or anti-coagulant medication

4 (29)

0 (0)

0.003a

MMT mean (range)

26.6 (22–30)

29.3 (28–30)

0.002*

INPH idiopathic normal pressure hydrocephalus, MI myocardial infarction, MMT mini mental test, SD standard deviation

* 2-sided t-test

a2-sided χ2-test

bDefined as either blood pressure > 140/90 or current use of blood pressure lowering medication

cRefers to current smoking, hypertension and treated hyperlipidemia

The frequency of ≥2 CMB was 43 % in INPH and 10 % in HeCo (Table 2; p = 0.01). However, frequency of ≥1 CMB did not differ between the two groups significantly, as it was 50 and 29 % in the INPH group and control group, respectively (p = 0.20). The distribution of CMB is presented in Table 3.
Table 2

Number of participants with cerebral microbleeds among idiopathic normal pressure hydrocephalus patients and healthy controls

 

INPH

Healthy controls

Number of subjects

14

41

0 CMB n (%)

7 (50)

29 (71)

1 CMB n (%)

1 (7)

8 (20)

≥2 CMB n (%)

6 (43)

4 (10)

≥5 CMB n (%)

4 (29)

0 (0)

Table 3

Location of the cerebral microbleeds among the patients with idiopathic normal pressure hydrocephalus and healthy controls

 

INPH

Healthy controls

Number of subjects with a CMB

7

12

Infratentorial, n (%)

4 (57)

2 (17)

Subcortical (“deep”), n (%)

5 (71)

6 (50)

Lobar, n (%)

4 (57)

4 (57)

A concerning finding was that the two INPH patients that died within 30 days of shunt placement surgery were the two patients with the highest number of CMB (34 and 174 CMB) in the study. The patient with 174 CMB suffered an intracerebral hemorrhage and the other patient had a sepsis with intrathecal bacteremia. Agreement between the observers for the presence of ≥2 CMB was 96 % (53/55) with a kappa value of 0.89 (95 % CI 0.73–1.0), agreement between the observers for the presence/absence of any CMB was 98 % (54/55) with a kappa value of 0.96 (95 % CI 0.88–1.0).

Discussion

This was a preliminary study, which revealed that the prevalence of CMBs was higher in patients with INPH than in healthy controls. Two serious adverse events occurred after shunt surgery, and these two patients had extensive CMB. There is no obvious causative link between CMB and the features of INPH such as large ventricles and periventricular edema [10]. The association is likely due to the fact that both CMB and INPH are associated with small vessel disease and vascular risk factors [47, 12]. Hence CMB are more common in patients with INPH. A similar association with vascular disease has also been proposed for CMB and dementia [9], and for CMB and increased risk of cerebral hemorrhage in patients treated with intravenous thrombolysis [13].

Our estimation of the prevalence of any CMB (50 %) was similar to that of patients with ischemic stroke (49 %) and other vascular disorders such as vascular dementia (59 %) and vascular Parkinsonism (56 %); whereas similar non-vascular degenerative disorders have lower prevalence: Non-vascular dementia 21 % and idiopathic Parkinsons disease 18 % [9, 14, 15]. Thus, our findings contribute to a better understanding of the etiology of INPH and support the suggested association between INPH, small vessel disease and vascular risk factors [6, 7]. Combined, these findings suggest that INPH is a combination of vascular disease and cerebrospinal fluid dynamic disorder. However, more detailed studies of the association between INPH and vascular risk factors are warranted. The two patients with the highest number of CMB died within 30 days after shunt placement. One of the causes of death (intracerebral hematoma) could reasonably be associated with CMB. It is well known that intracerebral hemorrhage can occur after severe complication to shunt placement [16]. As this is a small study, this might very well be a chance finding.

We used ≥2 CMB as outcome in this study. We did not use the presence of any (≥1) CMB as outcome as it is reasonable to argue that one CMB can be considered a normal variant rather than pathological: Although no CMB is most common among the elderly (85 %), the presence of any one CMB is also common (9 %); whereas only 6 % has ≥2 CMB [5, 6]. Also, ≥2 CMB is required to cause a clinical effect in diseases [13, 17]. A considerable weakness of this study is the small sample size. Another weakness of the study was that the mean age of the INPH patients was higher than for HeCo because the controls were not recruited to match specific INPH patients. Since CMB prevalence increases with age, a part of the difference in CMB prevalence might have been caused by difference in age. However, in support of this study,agreement between the reviewers (kappa 0.89) was in the upper tier compared to previous studies using T2* (kappa 0.33–0.88) [4].

Conclusion

Almost half of patients with INPH have several (≥2) CMB and several CMB seems to be more common among patients with INPH than among controls. If these preliminary data can be confirmed, it would support the hypothesis that INPH pathophysiology includes a vascular component.

Abbreviations

CMB: 

cerebral microbleeds

CSF: 

cerebrospinal fluid

HeCo: 

healthy controls

INPH: 

idiopathic normal pressure hydrocephalus

IQR: 

inter quartile range

SD: 

standard deviation

Declarations

Authors' contributions

EJ Co-designed the study, analyzed the material, wrote the first draft of the manuscript, KA Co-designed the study, gave critical comments to the manuscript, RB Co-designed the study, reviewed images for CMB, gave critical comments to the manuscript, NB Reviewed images for CMB, gave critical comments to the manuscript, AE Co-designed the study, gave critical comments to the manuscript, JM Main study designer, gave critical comments to the manuscript. All authors read and approved the final manuscript.

Acknowledgements

The authors want to acknowledge the assistance of research nurse Kristin Nyman in the data collection. This project was financed by the Swedish Research Council (Grant 621-2011-5216).

Competing interests

The authors declare that they have no competing interests.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Pharmacology and Clinical Neuroscience, Norrlands Universitetssjukhus, Umeå University
(2)
Department of Radiation Sciences, Umeå University
(3)
Centre for Biomedical Engineering and Physics, Umeå University

References

  1. Jaraj D, Rabiei K, Marlow T, et al. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014;82:1449–54.PubMed CentralView ArticlePubMedGoogle Scholar
  2. Malm J, Eklund A. Idiopathic normal pressure hydrocephalus. Pract Neurol. 2006;6:14–27.View ArticleGoogle Scholar
  3. Malm J, Graff-Radford NR, Ishikawa M, et al. Influence of comorbidities in idiopathic normal pressure hydrocephalus—research and clinical care: a report of the ISHCSF task force on comorbidities in INPH. Fluids Barriers CNS. 2013;10:22.PubMed CentralView ArticlePubMedGoogle Scholar
  4. Greenberg SM, Vernooij MW, Cordonnier C, et al. Microbleed study group. cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165–74.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, et al. Cerebral microbleeds in the population based AGES Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry. 2008;79:1002–6.View ArticlePubMedGoogle Scholar
  6. Vernooij MW, van der Lugt A, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam scan study. Neurology. 2008;70:1208–14.View ArticlePubMedGoogle Scholar
  7. Roob G, Schmidt R, Kapeller P, et al. MRI evidence of past cerebral microbleeds in a healthy elderly population. Neurology. 1999;52:991–4.View ArticlePubMedGoogle Scholar
  8. Poels MM, Ikram MA, van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam scan study. Neurology. 2012;78:326–33.View ArticlePubMedGoogle Scholar
  9. Shams S, Martola J, Granberg T, et al. Cerebral Microbleeds: different Prevalence, topography, and risk factors depending on dementia diagnosis-the Karolinska imaging dementia study. Am J Neuroradiol. 2015;36:661–6.View ArticlePubMedGoogle Scholar
  10. Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 suppl):S4–16.PubMedGoogle Scholar
  11. Gregoire SM, Chaudhary UJ, Brown MM, et al. The microbleed anatomical rating scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73:1759–66.View ArticlePubMedGoogle Scholar
  12. Krauss JK, Regel JP, Vach W, et al. Vascular risk factors and arteriosclerotic disease in idiopathic normal-pressure hydrocephalus of the elderly. Stroke. 1996;27:24–9.View ArticlePubMedGoogle Scholar
  13. Dannenberg S, Scheitz JF, Rozanski M, et al. Number of cerebral microbleeds and risk of intracerebral hemorrhage after intravenous thrombolysis. Stroke. 2014;45:2900–5.View ArticlePubMedGoogle Scholar
  14. Kim JH, Park J, Kim YH, Ma HI, Kim YJ. Characterization of cerebral microbleeds in idiopathic parkinson’s Disease. Eur J Neurol. 2015;22:377–83.View ArticlePubMedGoogle Scholar
  15. Yamada S, Saiki M, Satow T, et al. Periventricular and deep white matter leukoaraiosis have a closer association with cerebral microbleeds than age. Eur J Neurol. 2012;19:98–104.View ArticlePubMedGoogle Scholar
  16. Misaki K, Uchiyama N, Hayashi Y, Hamada J. Intracerebral hemorrhage secondary to ventriculoperitoneal shunt insertion–four case reports. Neurol Med Chir (Tokyo). 2010;50:76–9.View ArticleGoogle Scholar
  17. Knudsen KA, Rosand J, Karluk D, et al. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston Criteria. Neurology. 2001;56:537–9.View ArticlePubMedGoogle Scholar

Copyright

© Johansson et al. 2016

Advertisement